Evidence map›Paper›PMID 27789945›Full record

ArticleInternational journal of nanomedicine

Increased radiosensitivity of colorectal tumors with intra-tumoral injection of low dose of gold nanoparticles.

Minghan Shi, Benoit Paquette, Thititip Thippayamontri, Louis Gendron, Brigitte Guérin, Léon Sanche

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Golden era of radiosensitizers.Frontiers in veterinary science · 2024
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Minghan ShiDepartment of Nuclear Medicine and Radiobiology, Center for Research in Radiotherapy.
Benoit PaquetteDepartment of Nuclear Medicine and Radiobiology, Center for Research in Radiotherapy.
Thititip ThippayamontriDepartment of Nuclear Medicine and Radiobiology, Center for Research in Radiotherapy.
Louis GendronDepartment of Pharmacology-Physiology, University of Sherbrooke, Sherbrooke, QC, Canada.
Brigitte GuérinDepartment of Nuclear Medicine and Radiobiology, Center for Research in Radiotherapy.
Léon SancheDepartment of Nuclear Medicine and Radiobiology, Center for Research in Radiotherapy.
Université de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential of gold nanoparticles (GNPs) as radiosensitizers for the treatment of malignant tumors has been limited by the large quantities of GNPs that must be administered and the requirement for low-energy X-ray irradiation to optimize radiosensitization. In this study, we enhance the radiosensitivity of HCT116 human colorectal cells with tiopronin-coated GNPs (Tio-GNPs) combined with a low-energy X-ray (26 keV effective energy) source, similar to the Papillon 50 clinical irradiator used for topical irradiation of rectal tumors. Sensitizer enhancement ratios of 1.48 and 1.69 were measured in vitro, when the HCT116 cells were incubated with 0.1 mg/mL and 0.25 mg/mL of Tio-GNPs, respectively. In nude mice bearing the HCT116 tumor, intra-tumoral (IT) injection of Tio-GNPs allowed a 94 times higher quantity of Tio-GNPs to accumulate than was possible by intravenous injection and facilitated a significant tumor response. The time following irradiation, for tumors growing to four times their initial tumor volume (4Td) was 54 days for the IT injection of 366.3 μg of Tio-GNPs plus 10 Gy, compared to 37 days with radiation alone (

Indexed as

AnimalsColorectal NeoplasmsDNA Breaks, Double-StrandedGoldHCT116 CellsHumansInjections, IntralesionalMaleMetal NanoparticlesMice, NudeRadiation-Sensitizing AgentsTioproninXenograft Model Antitumor AssaysX-RaysGoldRadiation-Sensitizing AgentsTiopronincolorectal cancergold nanoparticlesmiceradiation enhancementX-ray

Identifiers

PMID27789945
PMCPMC5068480
OpenAlexW2531285344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.